Background The clinical efficacy of PD-1/PD-L1 inhibitors combined with chemotherapy (± targeted agents) in patients with proficient mismatch repair (pMMR) metastatic colorectal cancer (mCRC) remains unclear. This study systematically evaluated the efficacy of this regimen. Methods We searched PubMed, Web of Science, E...
Su-Min Lv, Chao-Yue Ma, Ze-Qi Tang et al.· Frontiers in Oncology· 0 citations
BACKGROUND
The prognostic value of circulating tumor DNA (ctDNA) remains controversial. This meta-analysis systematically evaluates the association between ctDNA status and prognosis in esophageal cancer (EC) and gastric cancer (GC) (including gastroesophageal junction cancer), stratified by resectability and treatment...
Shao-Qing Ding, Min-Yuan Ni, Ze-Qi Tang et al.· Critical reviews in oncology...· 0 citations
Background This study evaluated the efficacy of transarterial chemoembolization (TACE) combined with anti-vascular endothelial growth factor (VEGF)/tyrosine kinase inhibitors (TKIs) and programmed cell death protein 1 (PD-1)/programmed cell death protein ligand 1 (PD-L1) inhibitors in the treatment of unresectable hepa...
Xiao-Hong Kang, Shi-Yan Zhang, Qiu-Feng Zhang et al.· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.